Formulation Analysis

To ensure an accurate compound exposure, we offer non-GLP and GLP-compliant formulation analysis services of your test product. Our services are available to you as stand-alone services or integrated with a toxicity study. Formulation analyses can be conducted for in vivo and in vitro studies, upstream (e.g., stability analyses), and throughout your toxicity study (e.g., test compound concentration and homogeneity analyses).

Benefit From Integrated Formulation Analysis

NUVISAN’s formulation analysis services include stability testing of the formulation, complementing our in vitro and in vivo toxicity studies and analytical method validation. Our experts can develop and validate methods in our laboratories to support your in vivo toxicity safety package.

To support your project’s specific needs, our laboratories facilitate the analysis of a range of different formulations. For example, the test item can be analyzed in different matrices (e.g., PEG, CMC, and more), such as solutions, emulsions, and suspensions.

All formulation analysis services can be performed under GLP conditions. Accordingly, from start to finish, our chemists collaborate closely with you and our toxicologists to ensure the highest quality of data and results. Likewise, data reporting conforms with common standards, including according to SEND and the FDA.

Formulation Analysis Services Portfolio:

  • Analytical method development and validation according to ICH Q2(R1)
  • Assessment of formulation stability
  • Assessment of formulation homogeneity and test substance concentration